STOCK TITAN

EDOC Acquisition Corp. Announces Sponsor Approval of Extension of Deadline to Complete Business Combination

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Rhea-AI Summary

EDOC Acquisition Corp. (NASDAQ: ADOC) has received a request from its sponsor, American Physicians LLC, to extend the deadline for completing a business combination from November 12, 2021, to February 12, 2022. This extension marks the first of up to two allowed three-month extensions. In conjunction with this, the Sponsor plans to deposit $900,000 into the Company’s trust account by November 12, 2021. EDOC focuses on mergers and acquisitions within the healthcare sector in North America and Asia-Pacific.

Positive
  • Sponsor intends to deposit $900,000 into the trust account, supporting liquidity.
  • Extension provides additional time to identify a viable business combination.
Negative
  • Extension indicates challenges in finalizing a business combination by the original deadline.

Victor, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (NASDAQ: ADOC) (the “Company”), a publicly traded special purpose acquisition company, announced today that its sponsor, American Physicians LLC (the “Sponsor”), has requested that the Company extend the date by which the Company has to consummate a business combination from November 12, 2021 to February 12, 2022 (the “Extension”). The Extension is the first of up to two three-month extensions permitted under the Company’s governing documents. In connection with such Extension, the Sponsor has notified the Company that it intends to cause an aggregate of $900,000 to be deposited into the Company’s trust account on or before November 12, 2021.

About EDOC Acquisition Corp.

Edoc Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on businesses primarily operating in the healthcare sector in North America and Asia-Pacific.

Cautionary Note Regarding Forward-Looking Statements

This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact
Edoc Acquisition Corp.
7612 Main Street Fishers
Suite 200
Victor, NY 14564
Attention: Kevin Chen


FAQ

What is the purpose of EDOC Acquisition Corp's extension?

The extension allows EDOC Acquisition Corp. more time to finalize a business combination that aligns with its strategic focus.

How much is being deposited into EDOC's trust account?

The sponsor plans to deposit $900,000 into EDOC's trust account by November 12, 2021.

What are the new deadline dates for EDOC Acquisition Corp's business combination?

The new deadline for the business combination is February 12, 2022.

What does EDOC Acquisition Corp focus on for its business combinations?

EDOC focuses on businesses primarily operating in the healthcare sector across North America and Asia-Pacific.

Edoc Acquisition Corp.

NASDAQ:ADOC

ADOC Rankings

ADOC Latest News

ADOC Stock Data

10.32M
1.26M
0.45%
Shell Companies
Financial Services
Link
United States
Victor